Clinical Trials in San Francisco

Showing 8601-8620 of 12,991 trials

Pulse Oximeter and Respiratory Rate Test

NCT03797300

Assessment of Spry Health's Loop oximetry accuracy in profound hypoxia Assessment of Spry Health's Respiratory rate accuracy in normal conditions and profound hypoxia

HypoxiaHypercapniaHypocapnia

Spry Health12 participantsStarted Dec 2018

San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

NCT00818441

This study will explore the safety and efficacy of the oral PanHER inhibitor PF-00299804 in patients with adenocarcinoma of the lung who are either non-smokers (\<100 cigarette, cigar or pipe lifetime) or former light smokers ( less than 10 pack-years and stopped at least 15 years) or have known EGFR activating mutation; or patients with HER 2 amplification or mutation.

Carcinoma, Non-small Cell

Pfizer119 participantsStarted Mar 2009

Orange, California, United States • Orange, California, United States • Pleasant Hill, California, United States +38 more locations

Pulse Oximeter and Respiratory Rate Test

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Find Trials by Condition in San Francisco

Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis

Assessment of Cerebral Microvascular Circulation

Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients

Immune Monitoring in Sensitized Patients at Risk of Rejection

Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis

Digital Tools for Coping With Chronic Pain

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients

Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis

Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season